
Sunosi
TopicHeard in 1 episode across 1 show since Sep 2026
Sunosi (generic name solriamfetol) is a wakefulness-promoting medication used to treat excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea. It functions as a dual norepinephrine and dopamine reuptake inhibitor (NDRI) and is administered orally.
Episodes
1
across 1 show
First heard
Sep 2026
Expert statements
1
1 positive
Episodes per month
Public PodLume episodes featuring it, over the last year.
1
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 1 |
| Oct 2026 | 0 |
What experts have said about Sunosi
1 statement · 1 positive
Sunosi improves focus and energy while still allowing sleep.
“I find that it, it really dials in focus and energy in a way that still allows sleep”
Open the episode · #2553 - Andrew HubermanListen at 1:49:21
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
1 episode featuring Sunosi, newest first